CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.
about
Anti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral proteinTargeted cytotoxic therapy kills persisting HIV infected cells during ARTConditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function.Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirsHigh concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors.CD4-Pseudomonas exotoxin conjugates delay but do not fully inhibit human immunodeficiency virus replication in lymphocytes in vitro.Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.Antiviral therapy for human immunodeficiency virus infectionsVirus receptors: implications for pathogenesis and the design of antiviral agents.Unique insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells.Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1.Soluble CD4 enhances the efficacy of immunotoxins directed against gp41 of the human immunodeficiency virus.Reconsidering targeted toxins to eliminate HIV infection: you gotta have HAARTSoluble human CD4 elicits an antibody response in rhesus monkeys that inhibits simian immunodeficiency virus replicationImmunization of simian immunodeficiency virus-infected rhesus monkeys with soluble human CD4 elicits an antiviral response.Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication.Focus formation by the human immunodeficiency virus (HIV) in the immobilized MT-4 cell culture and its application to the evaluation of anti-HIV agents.Anti-HIV effects of CD4-Pseudomonas exotoxin on human lymphocyte and monocyte/macrophage cell lines.
P2860
Q28378710-401DC84D-A493-4620-9257-CF31AFE10AD1Q28538598-DDE3C066-CE5C-4C3A-A346-FB9A0D40D34AQ30424775-33BAB1A6-4F4F-4AEA-81F3-7AFD2CCAF23AQ33604776-F559F846-A91D-4BCA-9AA6-57A89D8C1BFDQ33760671-4DDFF788-B17C-484F-9723-7AABCE535725Q33896043-02168D48-6C80-4CAB-85BF-00744E6BC5FEQ34263852-6710343C-E218-490F-8584-0B28C3F15C39Q35325810-E8A4121F-2BA2-4537-8799-35CCCAD6CA66Q35366050-291F00D6-492D-452A-B627-1E2683D5C867Q35366667-88BBF657-8D5F-40B1-9FA9-10C545344CE0Q35828687-2F8A82AA-89C8-40F0-9FAE-1328300B9F01Q35851143-0417CC59-75DE-4553-8284-CD1AC1E6C06EQ36046969-2022DC71-D0BA-47A9-BFBC-15694FC8BE8FQ36077381-EF90B82E-EB00-47C0-AEDC-79F0D2311839Q37360689-97FE79C5-11B5-4629-958D-68F7BCDE39B3Q37518513-4A1AE936-4336-408D-AE6F-436DF0E2999FQ40834269-42ADC73C-F47E-41C1-BB8A-1D7322293B1CQ41648363-46FD0FD3-D402-4126-B1E4-72B71C9A1161Q41755956-41B33DE3-0D01-4802-823C-612E08B98774
P2860
CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.
description
1989 nî lūn-bûn
@nan
1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
CD4-Pseudomonas exotoxin hybri ...... immunodeficiency retroviruses.
@ast
CD4-Pseudomonas exotoxin hybri ...... immunodeficiency retroviruses.
@en
CD4-Pseudomonas exotoxin hybri ...... immunodeficiency retroviruses.
@nl
type
label
CD4-Pseudomonas exotoxin hybri ...... immunodeficiency retroviruses.
@ast
CD4-Pseudomonas exotoxin hybri ...... immunodeficiency retroviruses.
@en
CD4-Pseudomonas exotoxin hybri ...... immunodeficiency retroviruses.
@nl
prefLabel
CD4-Pseudomonas exotoxin hybri ...... immunodeficiency retroviruses.
@ast
CD4-Pseudomonas exotoxin hybri ...... immunodeficiency retroviruses.
@en
CD4-Pseudomonas exotoxin hybri ...... immunodeficiency retroviruses.
@nl
P2093
P2860
P356
P1476
CD4-Pseudomonas exotoxin hybri ...... immunodeficiency retroviruses.
@en
P2093
Chakrabarti S
Chaudhary VK
FitzGerald DJ
P2860
P304
P356
10.1073/PNAS.86.23.9539
P407
P577
1989-12-01T00:00:00Z